The rise of artificial intelligence is perfectly timed for the biopharmaceutical industry. Worldwide demand for innovative and effective treatments is escalating as major drugmakers encounter increased regulatory, pricing, and political challenges. In this demanding scenario, traditional industry operations need to accelerate. Fortunately, AI is beginning to facilitate the progress the industry requires. Companies like BMS and others are currently employing AI to transform pharma, enabling patients globally to overcome diseases.
Across the industry, AI tools are cutting drug development time by up to a factor of ten and significantly enhancing the most time-intensive pharma stage: clinical trials. STAT+ Exclusive Story Logged-in already?Access your account This content is exclusive to STAT+ subscribers. Access this article—and enjoy detailed analysis, newsletters, premium events, and news alerts. Logged-in already?Sign in Monthly Subscription $39 Annual cost: $468 $39/month Start Now Annual cost: $468 Starter Plan $30 for the first 3 months, followed by $399 annually $30 for 3 months Start Now Then $399/year Annual Subscription $399 Save 15% $399/year Start Now 15% savings 11+ Users Custom pricing Save at least 25%! Request A Quote Request A Quote 25% savings at minimum! 2-10 Users $300 per user, annually $300/year Start Now $300 annually per user View All Subscription Plans To continue reading, subscribe to STAT+. Subscribe Now
AI Revolutionizes Drug Development in Biopharma Industry
The Walt Disney Company has initiated a significant legal action against Google by issuing a cease-and-desist letter, accusing the tech giant of infringing on Disney’s copyrighted content during the training and development of generative artificial intelligence (AI) models without providing compensation.
As artificial intelligence (AI) advances and increasingly integrates into digital marketing, its influence on search engine optimization (SEO) is becoming significant.
MiniMax and Zhipu AI, two leading artificial intelligence companies, are reportedly preparing to go public on the Hong Kong Stock Exchange as early as January next year.
Denise Dresser, CEO of Slack, is set to leave her position to become Chief Revenue Officer at OpenAI, the company behind ChatGPT.
The film industry is experiencing a major transformation as studios increasingly incorporate artificial intelligence (AI) video synthesis techniques to improve post-production workflows.
AI is revolutionizing social media marketing by offering tools that simplify and enhance audience engagement.
The emergence of AI-generated influencers on social media signifies a major shift in the digital environment, sparking widespread debates about the authenticity of online interactions and the ethical concerns tied to these virtual personas.
Launch your AI-powered team to automate Marketing, Sales & Growth
and get clients on autopilot — from social media and search engines. No ads needed
Begin getting your first leads today
Lorem ipsum dolor sit amet consectetur adipisicing elit. Fuga dolor minus maiores. Aut vero expedita dicta, dolorem odit excepturi odio doloremque voluptatem repellat aliquam? Dolores nemo eum id pariatur! Nobis!
Create your own avatar to work for you — completely free of charge!
Sign up with
Google
We've sent a confirmation email to
Please check your inbox and click the link to complete your registration
Didn’t receive it? Check your Spam or Promotions folder
and get clients without any advertising investment!
Create and publish viral social media content on autopilot
AI sales managers work 24/7, with no need for sleep, food, or breaks, and speak all languages.
You have unsubscribed from the mailing list recklessly but successfully.
We are not saying goodbye and look forward to seeing you again.